Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

12.91

+0.26 (2.06%)

At close: Jan 29, 2026, 4:00 PM EST

12.90

-0.01 (-0.08%)

After-hours: Jan 29, 2026, 4:04 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2008 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2008 - 2019
Small Molecule Drugs	67.64M	Log In	Log In	Log In	Log In	Upgrade
Small Molecule Drugs Growth	-14.61%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2008 - 2019
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2008 - 2019
United States	67.64M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-14.61%	Log In	Log In	Log In	Log In	Upgrade